McDermott Beats Back Drug Patent Challenge for Depomed

The ruling, which Depomed said would extend its monopoly on the pain drug Gralise for a decade, is a huge relief for the small pharma company and its investors.

Sign up for a free trial now!'s Elite 15-day trial gives you:

  • All access pass to legal news across ALM's Network
  • News by Practice Area, available exclusively on
  • The free InPractice digital newsletter
  • Personalized legal news on the mobile App

During and after your trial, you'll receive the benefits of an ALM digital membership, including a subscription to the Newswire digital newsletter.